nach oben

International Journal of Behavioral Medicine

Erschienen in:

01.06.2009

Depressive Symptoms and Cervical Neoplasia in HIV+ Low-Income Minority Women with Human Papillomavirus Infection

verfasst von: Stacy M. Dodd, Deidre B. Pereira, Ilona Marion, Michele Andrasik, Rachel Rose, Trudi Simon, Mary Ann Fletcher, Joseph Lucci, Kevin Maher, Mary Jo O’Sullivan, JoNell Efantis-Potter, Michael H. Antoni

Erschienen in: International Journal of Behavioral Medicine | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Prior work has related elevated life stress to greater risk of cervical neoplasia in women with human immunodeficiency virus (HIV) and human papillomavirus (HPV).

Purpose

This study investigated associations between depressive symptoms and cervical neoplasia in HIV+ HPV+ women. Participants were 58 HIV+ HPV+ women.

Method

Participants underwent colposcopy, including HPV screening, Papanicolaou smear, and cervical biopsy to determine study eligibility. Eligible participants completed the Beck Depression Inventory (BDI) and the Center for Epidemiologic Studies-Depression (CES-D) scale.

Results

Presence and severity of clinically significant depressive symptomatology were associated with cervical neoplasia. Hierarchical logistic regression analysis revealed that women with greater depressive symptoms had marginally greater odds of presenting with cervical neoplasia (BDI: OR = 1.16, p = 0.092; CES-D: OR = 1.15, p = 0.067. Women with greater somatic depressive symptoms, specifically, had significantly greater odds of presenting with cervical neoplasia (BDI: OR = 1.86, p = 0.027; CES-D: OR = 1.56, p = 0.017).

Conclusion

These findings suggest that screening HIV+ women for somatic depression may help identify those at risk for cervical neoplasia. Future depression research with medical populations should discern somatic depressive symptoms from disease symptoms, as they may have important value in independently predicting health outcomes.

Joint United Nations Programme on HIV/AIDS. 2004 report on the global AIDS epidemic: 4th global report. Geneva: UN; 2004.

Anderson RN, Smith BL. Deaths: leading causes for 2002. Natl Vital Stat Reports 2005;53:67–70.

Center for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.1992;41:RR–17.

Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsaque X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518–27.PubMedCrossRef

Davis AT, Chakraborty H, Flowers L, Mosunjac MB. Cervical dysplasia in women with the human immunodeficiency virus (HIV): a correlation with HIV viral load and CD4+ count. Gynecol Oncol 2001;80:350–4.PubMedCrossRef

Hocke C, Leroy V, Morlat P, Rivel J, Duluc MC, Boulogne N, Tandonnet B, Dupon M, Brun JL, Dabis F. Cervical dysplasia and human immunodeficiency virus infection in women: prevalence and associated factors. Eur J Obstet Gynecol Reprod Biol 1998;81:69–76.PubMedCrossRef

Byrnes DM, Antoni MH, Goodkin K, Efantis-Potter J, Asthana D, Simon T, et al. Stressful events, pessimism, natural killer cell cytotoxicity, and cytotoxic/suppressor T cells in HIV+ black women at risk for cervical cancer. Psychosomatic Medicine 1998;60:714–22.PubMed

Pereira DB, Antoni MH, Danielson A, Simon T, Efantis-Potter J, Carver CS, Duran RE, Ironson G, Klimas N, Fletcher MA, O’Sullivan MJ. Stress as a predictor of symptomatic genital herpes virus recurrence in women with human immunodeficiency virus. J Psychosom Res 2003a;54:237–44.PubMedCrossRef

Pereira DB, Antoni MH, Danielson A, Simon T, Efantis-Potter J, Carver CS, Duran RE, Ironson G, Klimas N, O’Sullivan MJ. Life Stress and cervical squamous intraepithelial lesions in women with human papillomavirus and human immunodeficiency virus. Psychosom Med 2003b;65:427–34.PubMedCrossRef

10.

Tiersma ESM, van der Lee ML, Garssen B, Peters AAW, Visser AP, Fleuren GJ, et al. Psychosocial factors and the course of cervical intra-epithelial neoplasia: a prospective study. Gynecol Oncol 2005;97:879–86.PubMedCrossRef

11.

Chandra PS, Ravi V, Desai A, Subbakrishna DK. Anxiety and depression among HIV-infected heterosexuals—a report from India. J Psychosom Res 1998;45:401–9.PubMedCrossRef

12.

Evans DL, Ten Have TR, Douglas SD, Gettes DR, Morrison M, Chiappini MS, et al. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatr 2002;159:1752–9.PubMedCrossRef

13.

Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, HIV Epidemiology Research Study Group, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. J Am Med Assoc 2001;285:1466–74.CrossRef

14.

Leserman J, Petitto JM, Gu H, Gaynes BN, Barroso J, Golden RN, et al. Progression to AIDS, a clinical AIDS condition, and mortality: psychosocial and physiological predictors. Psychol Med 2002;32:1059–73.PubMedCrossRef

15.

Sahs JA, Goetz R, Reddy M, Rabkin JG, Williams JB, Kertzner R, et al. Psychological distress and natural killer cells in gay men with and without HIV infection. Am J Psychiatry 1994;151:1479–84.PubMed

16.

Vedhara K, Schifitoo G, McDermott M. Disease progression in HIV-positive women with moderate to severe immunosuppression: the role of depression. Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Behav Med 1999;25:43–7.PubMedCrossRef

17.

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561–71.PubMed

18.

Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385–401.CrossRef

19.

Weiser SD, Riley ED, Ragland K, Hammer G, Clark R, Bangsberg DR. Brief report: factors associated with depression among homeless and marginally housed HIV-infected men in San Francisco. J Gen Intern Med 2006;21:61–4.PubMedCrossRef

20.

Sheehan TJ, Fifield J, Reisine S, Tennen H. The measurement structure of the Center for Epidemiologic Studies Depression Scale. J Pers Assess 1995;64:507–21.PubMedCrossRef

21.

Bennetts A, Irwig L, Oldenburg B, Simpson JM, Mock P, Boyes A, et al. PEAPS-Q: a questionnaire to measure the psychosocial effects of having an abnormal pap smear. J Clin Epidemiol 1995;48:1235–43.PubMedCrossRef

22.

Sarason IG, Johnson JH, Siegel JM. Assessing the impact of life change: development of the Life Experiences Survey. J Consult Clin Psychol 1978;46:932–46.PubMedCrossRef

23.

Phelps RM, Smith DK, Heilig CM, Gardner LI, Carpenter CC, Klein RS, Jamieson DJ, Vlahov D, Schuman P, Holmberg SD. Cancer incidence in women with or at risk for HIV. Int J Cancer 2001;94:753–7.PubMedCrossRef

24.

Beck AT, Steer RA, Brown GK. Manual for the beck depression inventory, 2nd ed. San Antonio: Psychological Corporation; 1996.

25.

Das AK, Olfson M, McCurtis HL, Weissman MM. Depression in African Americans: breaking barriers to detection and treatment. J Fam Pract 2006;55:30–9.PubMed

26.

Silverstein B. Gender differences in the prevalence of somatic versus pure depression: a replication. Am J Psychiatry 2002;159:1051–2.PubMedCrossRef

27.

Perkins DO, Leserman J, Stern RA, Baum SF, Liao D, Golden RN, et al. Somatic symptoms and HIV infection: relationship to depressive symptoms and indicators of HIV disease. Am J Psychiatr 1995;152:1776–81.PubMed

28.

Farinpour R, Miller EN, Staz P, Selnes OA, Cohen BA, Becker JT, et al. Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS). J Clin Exp Neuropsychol 2003;25:654–70.PubMedCrossRef

29.

Bais AG, Beckmann I, Lindemans J, Ewing PC, Meijer CJLM, Snijders PJF, et al. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions. J Clin Pathol 2006;58:1096–100.CrossRef

Titel: Depressive Symptoms and Cervical Neoplasia in HIV+ Low-Income Minority Women with Human Papillomavirus Infection
verfasst von: Stacy M. Dodd
Deidre B. Pereira
Ilona Marion
Michele Andrasik
Rachel Rose
Trudi Simon
Mary Ann Fletcher
Joseph Lucci
Kevin Maher
Mary Jo O’Sullivan
JoNell Efantis-Potter
Michael H. Antoni
Publikationsdatum: 01.06.2009
Verlag: Springer US
Erschienen in: International Journal of Behavioral Medicine / Ausgabe 2/2009
Print ISSN: 1070-5503
Elektronische ISSN: 1532-7558
DOI: https://doi.org/10.1007/s12529-008-9025-1

Springer Medizin

Abstract

Background

Purpose

Method

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2009

Development and Psychometric Properties of the World Health Organization Quality of Life Assessment Instrument (WHOQOL-100) in Portugal

Health Behavior and Protective Factors Among School Children in Four African Countries

Measurement Instruments in Behavioral Medicine

Preliminary Evidence for the Cross-Cultural Utility of the Type D Personality Construct in the Ukraine

Increased Anxiety and Depression in Danish Cardiac Patients with a Type D personality: Cross-Validation of the Type D Scale (DS14)

The Factor Structure of the Illness Attitude Scales in A German Population